La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Oncology Institute Gestion
Gestion contrôle des critères 2/4
Oncology Institute's CEO is Dan Virnich, appointed in Jun 2023, has a tenure of 1.17 years. total yearly compensation is $808.13K, comprised of 56.3% salary and 43.7% bonuses, including company stock and options. directly owns 0.77% of the company’s shares, worth $200.44K. The average tenure of the management team and the board of directors is 1.8 years and 2.8 years respectively.
Informations clés
Dan Virnich
Directeur général
US$808.1k
Rémunération totale
| Pourcentage du salaire du PDG | 56.3% |
| Durée du mandat du directeur général | 1.2yrs |
| Propriété du PDG | 0.8% |
| Durée moyenne d'occupation des postes de direction | 1.8yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 2.8yrs |
Mises à jour récentes de la gestion
Recent updates
A Piece Of The Puzzle Missing From The Oncology Institute, Inc.'s (NASDAQ:TOI) 28% Share Price Climb
Jul 19
The Oncology Institute, Inc. (NASDAQ:TOI) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
May 05Not Many Are Piling Into The Oncology Institute, Inc. (NASDAQ:TOI) Stock Yet As It Plummets 28%
Mar 21Is Oncology Institute (NASDAQ:TOI) A Risky Investment?
Mar 05The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 49% But Many Are Still Ignoring The Company
Nov 10The Oncology Institute swings to Q2 GAAP loss per share from year-ago profit
Aug 09Shareholders Shouldn’t Be Too Comfortable With Oncology Institute's (NASDAQ:TOI) Strong Earnings
May 18Companies Like Oncology Institute (NASDAQ:TOI) Are In A Position To Invest In Growth
Mar 16Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$59m |
| Mar 31 2024 | n/a | n/a | -US$60m |
| Dec 31 2023 | US$808k | US$455k | -US$68m |
| Sep 30 2023 | n/a | n/a | -US$61m |
| Jun 30 2023 | n/a | n/a | -US$50m |
| Mar 31 2023 | n/a | n/a | -US$40m |
| Dec 31 2022 | US$3m | US$446k | US$68k |
| Sep 30 2022 | n/a | n/a | -US$1m |
| Jun 30 2022 | n/a | n/a | -US$2m |
| Mar 31 2022 | n/a | n/a | US$6m |
| Dec 31 2021 | US$8m | US$263k | -US$11m |
| Sep 30 2021 | n/a | n/a | -US$6m |
| Jun 30 2021 | n/a | n/a | -US$3m |
| Mar 31 2021 | n/a | n/a | -US$5m |
| Dec 31 2020 | US$419k | US$214k | -US$14m |
Rémunération vs marché: Dan's total compensation ($USD808.13K) is about average for companies of similar size in the US market ($USD680.04K).
Rémunération et revenus: Dan's compensation has been consistent with company performance over the past year.
PDG
Dan Virnich (45 yo)
1.2yrs
Titularisation
US$808,129
Compensation
Dr. Daniel Virnich, also known as Dan, M.D., M.B.A., FACHE, is Chief Executive Officer of The Oncology Institute Inc. since June 2023 and serves as its Executive Director since June 13, 2024. He served as...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman of the Board | 4.8yrs | US$162.40k | 0.34% $ 88.7k | |
| CEO & Executive Director | 1.2yrs | US$808.13k | 0.77% $ 200.4k | |
| Chief Financial Officer | 2.3yrs | US$801.74k | 0.21% $ 55.7k | |
| Chief Medical Officer | 2.8yrs | US$591.28k | 0.056% $ 14.6k | |
| Chief Operations Officer | less than a year | pas de données | pas de données | |
| General Counsel | 9.6yrs | pas de données | pas de données | |
| Chief People Officer | no data | pas de données | pas de données | |
| Chief Development Officer | less than a year | pas de données | pas de données |
1.8yrs
Durée moyenne de l'emploi
46yo
Âge moyen
Gestion expérimentée: TOI's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman of the Board | 4.8yrs | US$162.40k | 0.34% $ 88.7k | |
| CEO & Executive Director | less than a year | US$808.13k | 0.77% $ 200.4k | |
| Independent Director | 1.9yrs | US$160.32k | 0.12% $ 30.5k | |
| Vice Chairman | 2.8yrs | US$1.34m | 0.55% $ 144.2k | |
| Independent Director | 2.8yrs | US$188.81k | 0.095% $ 24.6k | |
| Director | 1.9yrs | US$143.70k | 0.038% $ 10.0k | |
| Independent Director | 2.8yrs | US$171.89k | 0.078% $ 20.4k | |
| Independent Director | 4.4yrs | US$180.22k | 0.12% $ 30.6k | |
| Independent Director | 2.8yrs | US$177.53k | 0.084% $ 21.8k |
2.8yrs
Durée moyenne de l'emploi
62.5yo
Âge moyen
Conseil d'administration expérimenté: TOI's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.